AstraZeneca Stock News

Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the company confirmed Thursday. "We are aware a small number of our employees in China are under investigation and we have no further information to share at this point," an AstraZeneca spokesperson told CNBC by email.

AstraZeneca PLC (LSE:AZN) has confirmed that five current and former employees in China are being held by police for questioning. The individuals, all Chinese nationals, worked in the company's oncology division marketing cancer treatments, with the police detentions made in the city of Shenzhen earlier this summer.

The police in China have detained five current and former employees of AstraZeneca for questioning about potential illegal activities, Bloomberg News reported on Thursday, citing people familiar with the matter.

AstraZeneca (LON: AZN) share price is firing on all cylinders as it sits on its all-time high. It has soared in the last five consecutive weeks, the longest streak since April 2023.

British biotech giant AstraZeneca PLC (LSE:AZN) has rebuffed claims that it is moving its vaccine operations to the US. A Financial Times report suggested that AstraZeneca could relocate its vaccine manufacturing operations to Philadelphia due to the Labour government' plans to cut state aid.

AstraZeneca has warned it could relocate its vaccine manufacturing site from the UK to the U.S. amid a deadlock in negotiations with the Labour government over plans to cut state aid promised to the project, the Financial Times reported on Thursday.

This column is part of the eighth annual Heard on the Street stock picking contest.

In the ever-evolving pharmaceutical landscape, financial stability and business resilience are crucial for long-term success. S&P Global, a leading financial information firm, recently released a comprehensive report evaluating the world's top pharmaceutical companies based on their business and financial risk profiles.